Skip to main content
. 2014 Jan 3;16(1):101. doi: 10.1186/ar4428

Table 2.

Beneficial and detrimental effects of Core Set and ACR20 on trials in rheumatoid arthritis

Beneficial effects Detrimental effects
Selected outcome measures most likely to change with treatment
Dichotomized a continuous measures of response
Made uniform trial outcome measures across studies, making comparisons possible
 
Decreased the number of outcomes from >10 to 7 and then to 1 (ACR20)